Tci Wealth Advisors, Inc. Karuna Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$93.97 - $143.33 $5,450 - $8,313	58 New	58 $7,000
Q1 2022 Apr 29, 2022	SELL	$98.9 - $132.37 $4,153 - $5,559	-42 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$101.2 - $125.87 $1,113 - $1,384	11 Added 35.48%	42 $5,000
Q2 2021 Aug 02, 2021	BUY	$107.45 - $135.95 $1,289 - $1,631	12 Added 63.16%	31 $4,000
Q1 2021 Apr 29, 2021	BUY	$95.46 - $133.08 $1,813 - $2,528	19 New	19 $2,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.